Form 4: VYNE Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Mutya Harsch, CHIEF LEGAL OFFICER AND GC of VYNE Therapeutics Inc., reported a transaction in 22,516 shares of common stock on July 23, 2026.
Summary
- Tax/exercise-price withholding: disposed of 22,516 Common Stock at $0.90 ($20,210) on July 23, 2026; holds 95,918 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mutya Harsch — Officer (CHIEF LEGAL OFFICER AND GC)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Tax/exercise-price withholding | Common Stock | 22,516 | $1 | $20.2K | 95,918 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Tax/exercise-price withholding (22,516 shares) |
Keywords
insider transaction, Form 4, VYNE, VYNE Therapeutics Inc., neutral, Mutya Harsch
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.